1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014.

Slides:



Advertisements
Similar presentations
Why an international standard on Record Management?
Advertisements

Project Quality Plans Gillian Sandilands Director of Quality
World Health Organization
CHAPTER 4 E-ENVIRONMENT
GReening business through the Enterprise Europe Network EN Giovanni FRANCO European Commission Enterprise and Industry EN
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
22000 Food Safety Management Systems
IS Audit Function Knowledge
Regulatory Body MODIFIED Day 8 – Lecture 3.
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Preventing and Managing a Crisis. Overview This session will cover how to: Develop a crisis communications plan Prevent crises Prepare for crises Implement.
Are you ready for a recall? Medical Device Regulatory, Reimbursement and Compliance Congress March 28, 2007 Willie R. Bryant, Jr. Consultant Stericycle,
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Ship Recycling Facility Management System IMO Guideline A.962
Justina A. Molzon, MS Pharm, JD
Pharmacovigilance obligations of the Pharmaceutical companies in India
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
Chapter 3 資訊安全管理系統. 4.1 General Requirements Develop, implement, maintain and continually improve a documented ISMS Process based on PDCA.
Drug Submissions: Review Process Agnes V. Klein, MD Biologics and Genetic Therapies Directorate February, 2003 www/hc-sc.gc.ca/hpb-dgps/therapeut.
CERTIFICATION In the Electronics Recycling Industry © 2007 IAER Web Site - -
© 2011 Underwriters Laboratories Inc. All rights reserved. This document may not be reproduced or distributed without authorization. ASSET Safety Management.
Chapter 6 CRISIS MANAGEMENT. Introduction - Crisis: ◦is a situation that specifically involves a pharmaceutical product, medical device or activity with.
PwC 21 CFR Part 11 – A Risk Management Perspective Patrick D. Roche 07 March 2003, Washington D.C.
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. REGULATORY INTELLIGENCE: INDUSTRY’S BEST PRACTICE OMICS 5 th International Pharmaceutical.
1 Thank you for visiting our site and welcome to the “Introduction to ISO 22000” Presentation that you requested. For more information.
Circuit Rider Training Program (CRTP) Circuit Rider Professional Association Annual General Meeting and Conference August 30, 2012.
Programme Performance Criteria. Regulatory Authority Objectives To identify criteria against which the status of each element of the regulatory programme.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
ISO Environmental Management Systems 1 ISO LEGAL AND OTHER REQUIREMENTS.
Compliance Promotion Formalizing an Approach to Support Stakeholder Compliance.
The Revised Kyoto Convention Seminar on the Harmonization Convention Moscow October 2006.
FDA Regulatory and Compliance Symposium
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
ISO DOCUMENT CONTROL. ISO Environmental Management Systems2 Lesson Learning Goals At the end of this lesson you should be able to: 
Swedish IRRS mission 6-17 Feb 2012 Ongoing work after the IRRS mission Elisabeth Öhlén, Ingemar Lund, Lars Skånberg.
Registration Speaker Susan Robinson Job Title Area Manager
SEVESO II transposition and implementation: Possible approaches and lessons learned from member states and new member states SEVESO II transposition and.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
BRC Packaging ISSUE 5 Global Standard for Packaging and Packaging Materials.
Internal Audit Section. Authorized in Section , Florida Statutes Section , Florida Statutes (F.S.), authorizes the Inspector General to review.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
Horst Kastrup September 8, 2015 The “T” in PETD.  The views and opinions expressed in the following PowerPoint slides are those of the individual presenter.
Safety Management Systems Session Four Safety Promotion APTA Webinar June 9, 2016.
GCP (GOOD CLINICAL PRACTISE)
RAC Regulatory Affairs Certification
GMP IN THE CURRENT REGULATORY EMVIRONMENT
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
Globally Harmonized System
CMS Policy & Procedures
The Information Professional’s Role in Product Safety
Investigator of Record – Definition
CDRH 2010 Strategic Priorities
FDA GUI Summary of Contract Manufacturing Arrangement for Drugs: Quality Agreements November This summary was prepared by the Rx-360.
World Health Organization
Investigator of Record – Definition
Chapter 8 Developing an Effective Ethics Program
Dr Manisha Shridhar Regional Advisor WHO-SEARO
REAL WORLD CASE STUDY.
EUnetHTA Assembly May 2018.
Presentation transcript:

1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014

Ensure the company maintains worldwide compliance with regulatory policy requirements Need a formal process for demonstrating that the company: –Monitors published regulatory policies; –Assesses impact of new legislation or guidance (regulatory policy documents); –Makes changes as necessary to existing company procedures; –Creates new procedures as needed for new policies; and –Develops and provides staff training in new/modified procedures as needed Expectation It’s just good business 2

Scope Challenge: Global Coverage Where are the company’s business interests? What are the regional issues? What are the local (country) issues? How do you stay informed about new or modified policies? 3

Scope Challenge: Policy Topics DIA Labeling Biosimilars Manufacturing Clinical Trials Meta-analysis Multi-region Clinical Trials Data Sharing Transparency Ethics Regulatory Procedures Biomarkers Inspections Health Technology Assessment Pharmacovigilance Serialization Trademarks Track & Trace Vaccines Antibiotic Resistance Informatics Electronic Submissions ICH Innovation Packaging Drug Development Medical Devices Advertising & Promotion Toxicology Pediatrics Benefit Risk In Vitro Diagnostics Innovation Consumer Care/Over-the-Counter Drug Shortages Variations Abuse Liability Generics Social Media Rare Diseases Orphan Drugs Harmonization Data Standards Anti-Counterfeiting 4

Scope Challenge: Understanding Your Organization Who are the subject matter experts and points of contact? Who are the regional and country contacts? Who are the business process owners who can do the impact analysis? What is the chain of command for clearance of revised procedures? 5

Identify your trusted intelligence sources –Explore regulatory intelligence services (e.g., Cortellis) –Engage regional/country contacts to monitor health authorities’ activities to identify regulatory policy changes Develop business rules for filtering intelligence –Identify discrete subset that represents new policy Laws, decrees, regulations, guidelines, guidance, etc. –Identify regions/countries of interest –Identify scope of regulatory policy topics in business scope Developing Your Process 6

7 Cortellis Regulatory Intelligence Weekly Alert HTML/unstructured text format Search functionality limited; sorting limited to by country as presented Average document listings per week HTML/unstructured text format Search functionality limited; sorting limited to by country as presented Average document listings per week

Compliance Weekly Alert 8 Macro converts to MS Excel format List filtered based on compliance business rules Range document listings per week Easy sort and search capability by multiple categories (country, category, date, custom- defined) Macro converts to MS Excel format List filtered based on compliance business rules Range document listings per week Easy sort and search capability by multiple categories (country, category, date, custom- defined)

Ensure resources available for consistent, real-time monitoring of intelligence sources Establish frequency (e.g., weekly) for generating report of newly published global policy documents Developing Your Process Regulatory Policy Compliance - Alerts 9

Document Your Process EXAMPLE Clarify roles and responsibilities –Use a “swim lane” approach Include steps for: Assessing potential business impact Potential for local or global impact Specify who (e.g., business process owner) makes the final determination regarding if a new or updated regulatory policy document requires compliance action Assigning document to business process owner for detailed impact analysis Maintain log of how each document was handled 10

Assess the regulatory policy Document actions deemed required per impact assessment Implement actions required Train relevant staff Communicate availability of modified or new business process Specify Expectations for Impact Assessment and Process Modification 11

Be prepared to demonstrate compliance by being able to produce: –Documented process –Intelligence sources –Tracking –Impact assessments –Training records –Modified business procedures –Communication to affected staff Demonstrating Compliance 12

Monitor process to ensure impact analysis and necessary process modifications are completed for each document Periodically evaluate the regulatory policy compliance process to ensure thoroughness, efficiency, accuracy Re-publish and retrain staff on the regulatory policy compliance process as needed Maintain the Regulatory Compliance Process! 13

14